Fulcrum Therapeutics Inc.
FULC | NASDAQ
$3.80
$0 (+0.13%)
Sep 22, 2026, 10:25 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -9.58 | -29.38 | -4.25 | -3.10 | -7.97 | -4.34 |
PEG Ratio | -0.02 | 0.33 | 0.13 | -0.53 | 0.45 | 0.19 |
PS Ratio | n/a | 3.64 | 147.54 | 51.65 | 32.64 | 33.65 |
PB Ratio | 2.05 | 1.20 | 1.76 | 1.65 | 2.96 | 3.12 |
P/FCF Ratio | -11.87 | -116.72 | -4.52 | -3.31 | -7.80 | -5.40 |
P/OCF Ratio | -11.93 | -131.35 | -4.55 | -3.37 | -7.97 | -5.53 |
OCF/S Ratio | n/a | -2.77 | -3.24K | -1.53K | -409.53 | -608.13 |
Debt / Equity Ratio | 0.02 | 0.04 | 0.05 | 0.07 | n/a | 0 |
Quick Ratio | 27.40 | 22.63 | 17.71 | 12.41 | 11.80 | 4.33 |
Current Ratio | 27.40 | 22.63 | 17.71 | 12.41 | 11.77 | 4.23 |
Asset Turnover | n/a | 0.31 | 0.01 | 0.03 | 0.08 | 0.07 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -21.46% | -4% | -41.39% | -55.23% | -38.22% | -74.40% |
Return on Assets | -20.44% | -3.73% | -37.77% | -48.47% | -34.40% | -54.65% |
Return on Invested Capital | -23.84% | -8.69% | -44.95% | -52.95% | -37.56% | -69.61% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 20.77% | -2.46K% | -1.11K% | -263.73% | -569.18% |
Net Profit Margin | n/a | -12.16% | -3.47K% | -1.73K% | -421.89% | -802.66% |
Pretax Profit Margin | n/a | -12.16% | -3.47K% | -1.73K% | -421.89% | -802.66% |
Operating Profit Margin | n/a | -27.37% | -3.95K% | -1.77K% | -422.97% | -811.64% |
FCF Margin | n/a | -3.12% | -3.26K% | -1.56K% | -418.47% | -623.34% |
EBITDA Margin | n/a | -22.80% | -3.39K% | -1.73K% | -408.77% | -784.68% |
Add to Watchlist
Select watchlists to add or remove FULC